Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.
Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores
Gyawu Rehman
Valproic acid is a widely used medication for the treatment of epilepsy and bipolar disorder. It exerts its therapeutic effects through various molecular mechanisms, including enhancement of GABAergic neurotransmission, modulation of signaling pathways, and neuroprotective properties. These mechanisms contribute to its efficacy in controlling seizures and stabilizing mood. However, VPA is not without its drawbacks, as it can be associated with hepatotoxicity, gastrointestinal disturbances, weight gain, hair loss, and teratogenicity. This article provides an overview of the molecular and therapeutic potential of VPA, as well as its associated toxicity. It highlights the need for careful monitoring and informed decision-making when prescribing VPA, while also discussing the ongoing research and development of safer derivatives.